metaPreg - Oxazepam (Psy and mixed indications) during pregnancy

Oxazepam (Psy and mixed indications) updated on 02-10-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	1.01 [0.72, 1.41]	-	1 study	49,532	843	not evaluable	ROB	-
Cleft lip with or without cleft palate	8.17 [1.41, 47.28]	-	1 study	277	8	not evaluable	ROB	15.82 [2.17; .]
Congenital heart defects	0.99 [0.55, 1.78]	-	1 study		843	not evaluable	ROB	-
Genetic syndromes and microdeletions	0.43 [0.23, 0.81]	-	1 study	2,280		not evaluable	ROB	4.08 [.; 1.78]
Major congenital malformations	1.01 [0.72, 1.41]	-	1 study	49,532	843	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	1.48 [1.02, 2.14]	-	1 study	27,149	160	not evaluable	ROB	2.32 [1.17; .]
Hide endpoints reported in only one study ...